View All Documents & Correspondence
A Composition For Treating Inflammation
Abstract: The present disclosure relates to a composition comprising green tea extract and a compound selected from the group consisting of rutin, rutin hydrate, rutin trihydrate, and combinations thereof which at specific w/w ratios is able to curb the effects of inflammation. Also provided are the methods of preparation and usage of the same.
Notices, Deadlines & Correspondence
Patent Information
Applicants
ITC LIMITED
Inventors
1. NARAYANAPERUMAL, Jeyaparthasarathy
2. GOPAL, Ganesh
Specification
Claims:1. A synergistic composition comprising:
a) green tea extract; and
b) a compound selected from the group consisting of rutin, rutin hydrate, rutin trihydrate, and combinations thereof,
wherein the green tea extract to the compound w/w ratio in said composition is in the range of 1:0.125–1:5.
2. The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is in the range of 1:0.5–1:2.
3. The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is 1:0.5.
4. The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is 1:0.75.
5. The composition as claimed in claim 1, wherein the green tea extract to rutin trihydrate w/w ratio in said composition is 1:2.
6. The composition as claimed in any of the claims 1-5, further comprising:
a) at least one carrier;
b) at least one diluent; and
c) at least one excipient.
7. A method for preparing a composition as claimed in claim 1, comprising:
a) obtaining green tea extract;
b) obtaining rutin trihydrate; and
c) contacting the green tea extract and rutin trihydrate thereof to obtain said composition.
8. A method for preparing a composition as claimed in any of the claims 1-6, comprising:
a) obtaining green tea extract;
b) obtaining rutin trihydrate;
c) obtaining at least one carrier;
d) obtaining at least one diluent;
e) obtaining at least one excipient; and
f) contacting the green tea extract, rutin trihydrate, the at least one carrier, the at least one diluent, and the at least one excipient to obtain said composition.
9. The composition as claimed in any of the claims 1-6, wherein said composition inhibits inflammatory response by inhibiting activated - NF-?B protein.
10. The composition as claimed in any of the claims 1-6, wherein said composition inhibits inflammatory response by inhibiting monocyte chemotactic activity.
11. The composition as claimed in any of the claims 1-6, wherein said composition is used for preparing formulations for anti-inflammatory products.
, Description:AS ATTACHED
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | Form 5 [14-06-2017(online)].pdf | 2017-06-14 |
| 2 | Form 3 [14-06-2017(online)].pdf | 2017-06-14 |
| 3 | Drawing [14-06-2017(online)].pdf | 2017-06-14 |
| 4 | Description(Complete) [14-06-2017(online)].pdf_40.pdf | 2017-06-14 |
| 5 | Description(Complete) [14-06-2017(online)].pdf | 2017-06-14 |
| 6 | 201741020845-Proof of Right (MANDATORY) [22-08-2017(online)].pdf | 2017-08-22 |
| 7 | 201741020845-FORM-26 [22-08-2017(online)].pdf | 2017-08-22 |
| 8 | Correspondence by Agent_Power of Attorney_24-08-2017.pdf | 2017-08-24 |
| 9 | IMPORTANT LETTER FROM NBA.pdf | 2019-04-03 |
| 10 | 201741020845-FORM 18 [25-03-2021(online)].pdf | 2021-03-25 |
| 11 | 201741020845-FER.pdf | 2025-07-23 |
| 12 | 201741020845-FORM 3 [17-09-2025(online)].pdf | 2025-09-17 |
Search Strategy
| 1 | 201741020845_SearchStrategyNew_E_SearchStrategyE_17-07-2025.pdf |